Q4 & FY 25 Earnings Conference Call- Transcript

Jupiter Life Line Hospitals reported FY25 total income of INR 1,261.5 crores, up 17.5% YoY, with EBITDA of INR 296.6 crores (+22.5%) at a 23.5% margin and PAT of INR 193.5 crores at a 15.3% margin. Q4 revenue grew 12.1% YoY to INR 326.7 crores with EBITDA margin of 23.9%, though PAT dipped 0.9% YoY due to higher depreciation. ARPOB rose 10.4% to INR 60,600 and occupancy improved 150 bps to 65.3%, with Thane at 72.1%, Pune at 65.5%, and Indore at 54.9%. Management highlighted progress toward its 2,500-bed, 6-hospital Western India target, with 78 new beds commissioned at Indore in January 2025, Dombivli hospital expected in Q1 FY27 (Phase 1: ~250 beds), and Pune greenfield (500 beds, ~INR 500 crores capex excluding land) at excavation stage. The company raised INR 250 crores debt at the Indore subsidiary and secured INR 350 crores sanctioned loan (INR 75 crores drawn) at the listed entity, with cash position of ~INR 600 crores, to fund future greenfield and acquisition opportunities. Management stated ARPOB growth going forward should track inflation rather than the recent 10% pace.